申请人:The United States of America, as Represented by Secretary, Department of Health and Human Service
公开号:US20170144984A1
公开(公告)日:2017-05-25
Disclosed are modulators of the human relaxin receptor 1, for example, of formula (I), wherein A, R
1
, and R
2
are as defined herein, that are useful in treating mammalian relaxin receptor 1 mediated facets of human health, e.g., cardiovascular disease. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the disclosure, and a method for therapeutic intervention in a facet of mammalian health that is mediated by a human relaxin receptor 1.